These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22271902)

  • 61. Somatic mutations in children with
    Fisher KE; Hsu AP; Williams CL; Sayeed H; Merritt BY; Elghetany MT; Holland SM; Bertuch AA; Gramatges MM
    Blood Adv; 2017 Feb; 1(7):443-448. PubMed ID: 29296959
    [TBL] [Abstract][Full Text] [Related]  

  • 62. GATA2 deficiency and related myeloid neoplasms.
    Wlodarski MW; Collin M; Horwitz MS
    Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
    Obiorah IE; Upadhyaya KD; Calvo KR
    Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
    Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS
    Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909
    [TBL] [Abstract][Full Text] [Related]  

  • 66. GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutation.
    Cortés-Lavaud X; Landecho MF; Maicas M; Urquiza L; Merino J; Moreno-Miralles I; Odero MD
    J Immunol; 2015 Mar; 194(5):2190-8. PubMed ID: 25624456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Somatic SETBP1 mutations in myeloid neoplasms.
    Makishima H
    Int J Hematol; 2017 Jun; 105(6):732-742. PubMed ID: 28447248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.
    Hsu AP; Sampaio EP; Khan J; Calvo KR; Lemieux JE; Patel SY; Frucht DM; Vinh DC; Auth RD; Freeman AF; Olivier KN; Uzel G; Zerbe CS; Spalding C; Pittaluga S; Raffeld M; Kuhns DB; Ding L; Paulson ML; Marciano BE; Gea-Banacloche JC; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2011 Sep; 118(10):2653-5. PubMed ID: 21670465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myeloid neoplasms with germline DDX41 mutation.
    Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
    Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Genomic aberrations in myelodysplastic syndromes and related disorders].
    Makishima H
    Rinsho Ketsueki; 2019; 60(6):600-609. PubMed ID: 31281151
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
    Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
    Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R; Mansat-De Mas V; Gelsi-Boyer V; Demur C; Murati A; Corre J; Prebet T; Bertoli S; Brecqueville M; Arnoulet C; Recher C; Vey N; Mozziconacci MJ; Delabesse E; Birnbaum D
    Oncotarget; 2015 Apr; 6(10):8388-96. PubMed ID: 25860933
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7.
    Wall M; Rayeroux KC; MacKinnon RN; Zordan A; Campbell LJ
    Haematologica; 2012 Dec; 97(12):1933-6. PubMed ID: 22875624
    [No Abstract]   [Full Text] [Related]  

  • 75. Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.
    Möllgård L; Saft L; Treppendahl MB; Dybedal I; Nørgaard JM; Astermark J; Ejerblad E; Garelius H; Dufva IH; Jansson M; Jädersten M; Kjeldsen L; Linder O; Nilsson L; Vestergaard H; Porwit A; Grønbæk K; Hellström-Lindberg E
    Haematologica; 2011 Jul; 96(7):963-71. PubMed ID: 21719884
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trilineage Dysplasia in an Adolescent With Germline GATA2 Mutation.
    Gardner JA; Devitt KA
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):392-393. PubMed ID: 30933029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
    Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
    Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
    Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
    Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.
    Tien FM; Hou HA; Tsai CH; Tang JL; Chiu YC; Chen CY; Kuo YY; Tseng MH; Peng YL; Liu MC; Liu CW; Liao XW; Lin LI; Lin CT; Wu SJ; Ko BS; Hsu SC; Huang SY; Yao M; Chou WC; Tien HF
    Blood Cancer J; 2018 Aug; 8(9):87. PubMed ID: 30190467
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monitoring and treatment of MDS in genetically susceptible persons.
    Davies SM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):105-109. PubMed ID: 31808891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.